Ftse Mib
33.154,05
-0,10%
DAX
18.235,45
0,17%
S&P 500
5.460,48
-0,41%
NASDAQ
17.732,60
-0,71%
Bitcoin
60.654,66
0,57%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. USOTC Teva Pharmaceutical Industries Ltd (PK) (TEVJF) Teva Pharmaceutical Industries Ltd (PK) (TEVJF) Notizie

TEVJF

Teva Pharmaceutical Indu... (PK) (TEVJF)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:TEVJF
DataOraFonteTitoloSimboloCompagnia
18/06/202422:11Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:TEVJFTeva Pharmaceutical Industries Ltd (PK)
10/06/202413:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:TEVJFTeva Pharmaceutical Industries Ltd (PK)
06/06/202422:05Edgar (US Regulatory)Form 8-K - Current reportUSOTC:TEVJFTeva Pharmaceutical Industries Ltd (PK)
05/06/202413:18Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:TEVJFTeva Pharmaceutical Industries Ltd (PK)
12/02/202413:01Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]USOTC:TEVJFTeva Pharmaceutical Industries Ltd (PK)
01/02/202414:03Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsUSOTC:TEVJFTeva Pharmaceutical Industries Ltd (PK)
07/08/202322:14Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]USOTC:TEVJFTeva Pharmaceutical Industries Ltd (PK)
20/06/202313:40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:TEVJFTeva Pharmaceutical Industries Ltd (PK)
15/06/202322:02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:TEVJFTeva Pharmaceutical Industries Ltd (PK)
09/06/202318:33Edgar (US Regulatory)Schedule 13g
(sc 13g/a)		USOTC:TEVJFTeva Pharmaceutical Industries Ltd (PK)
24/05/202322:29Edgar (US Regulatory)Specialized Disclosure Report (sd)USOTC:TEVJFTeva Pharmaceutical Industries Ltd (PK)
24/05/202322:16Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:TEVJFTeva Pharmaceutical Industries Ltd (PK)
10/05/202322:05Edgar (US Regulatory)Quarterly Report (10-q)USOTC:TEVJFTeva Pharmaceutical Industries Ltd (PK)
19/04/202322:18Edgar (US Regulatory)Annual Report to Security Holders (ars)USOTC:TEVJFTeva Pharmaceutical Industries Ltd (PK)
03/03/202313:03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)USOTC:TEVJFTeva Pharmaceutical Industries Ltd (PK)
01/03/202322:13Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)USOTC:TEVJFTeva Pharmaceutical Industries Ltd (PK)
10/02/202313:04Edgar (US Regulatory)Annual Report (10-k)USOTC:TEVJFTeva Pharmaceutical Industries Ltd (PK)
08/02/202322:23Edgar (US Regulatory)Securities Registration (ads, Immediate) (f-6ef)USOTC:TEVJFTeva Pharmaceutical Industries Ltd (PK)
03/08/202213:11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:TEVJFTeva Pharmaceutical Industries Ltd (PK)
15/03/202221:03Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:TEVJFTeva Pharmaceutical Industries Ltd (PK)
11/02/202218:26Edgar (US Regulatory)Schedule 13gUSOTC:TEVJFTeva Pharmaceutical Industries Ltd (PK)
10/02/202222:16Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)USOTC:TEVJFTeva Pharmaceutical Industries Ltd (PK)
27/10/202114:52Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:TEVJFTeva Pharmaceutical Industries Ltd (PK)
21/04/202122:12Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:TEVJFTeva Pharmaceutical Industries Ltd (PK)
05/08/202022:49Edgar (US Regulatory)Securities Registration: Business Combination (s-4)USOTC:TEVJFTeva Pharmaceutical Industries Ltd (PK)
05/08/202022:44Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:TEVJFTeva Pharmaceutical Industries Ltd (PK)
14/02/202018:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:TEVJFTeva Pharmaceutical Industries Ltd (PK)
14/02/201912:07Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:TEVJFTeva Pharmaceutical Industries Ltd (PK)
10/10/201322:13Edgar (US Regulatory)Report of Foreign Issuer (6-k)USOTC:TEVJFTeva Pharmaceutical Industries Ltd (PK)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:TEVJF

La tua Cronologia

NYSE
BMRG.WS
B Riley Principal Merger...
BIT
UC7T5R
Unicredit Bank
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network